Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    An Enquiry

    Menu

    Antihemophilic factor recombinant

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 8Bayer AG

    02 4Novo Nordisk

    03 6Takeda Pharmaceutical

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Bayer AG

    Germany
    IOPC
    Not Confirmed
    arrow

    Bayer AG

    Germany
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    ANTIHEMOPHILIC FACTOR (RECOMBINANT)

    Brand Name : KOVALTRY

    Dosage Form : KIT

    Dosage Strength : 250UNIT/VIAL

    Packaging : 2.5ML

    Approval Date :

    Application Number : 2451441

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Bayer AG

    Germany
    IOPC
    Not Confirmed
    arrow

    Bayer AG

    Germany
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    ANTIHEMOPHILIC FACTOR (RECOMBINANT)

    Brand Name : KOVALTRY

    Dosage Form : KIT

    Dosage Strength : 500UNIT/VIAL

    Packaging : 2.5ML

    Approval Date :

    Application Number : 2451468

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Bayer AG

    Germany
    IOPC
    Not Confirmed
    arrow

    Bayer AG

    Germany
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    ANTIHEMOPHILIC FACTOR (RECOMBINANT)

    Brand Name : KOVALTRY

    Dosage Form : KIT

    Dosage Strength : 1000UNIT/VIAL

    Packaging : 2.5ML

    Approval Date :

    Application Number : 2451476

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Bayer AG

    Germany
    IOPC
    Not Confirmed
    arrow

    Bayer AG

    Germany
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    ANTIHEMOPHILIC FACTOR (RECOMBINANT)

    Brand Name : KOVALTRY

    Dosage Form : KIT

    Dosage Strength : 2000UNIT/VIAL

    Packaging : 5ML

    Approval Date :

    Application Number : 2451484

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Bayer AG

    Germany
    IOPC
    Not Confirmed
    arrow

    Bayer AG

    Germany
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    ANTIHEMOPHILIC FACTOR (RECOMBINANT)

    Brand Name : KOVALTRY

    Dosage Form : KIT

    Dosage Strength : 3000UNIT/VIAL

    Packaging : 5ML

    Approval Date :

    Application Number : 2451492

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Bayer AG

    Germany
    IOPC
    Not Confirmed
    arrow

    Bayer AG

    Germany
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    Antihemophilic factor recombinant

    Brand Name : JIVI

    Dosage Form : POWDER FOR SOLUTION

    Dosage Strength : 500UNIT/VIAL

    Packaging : 500

    Approval Date :

    Application Number : 2481766

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Bayer AG

    Germany
    IOPC
    Not Confirmed
    arrow

    Bayer AG

    Germany
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    Antihemophilic factor recombinant

    Brand Name : JIVI

    Dosage Form : POWDER FOR SOLUTION

    Dosage Strength : 1000UNIT/VIAL

    Packaging :

    Approval Date :

    Application Number : 2481774

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Bayer AG

    Germany
    IOPC
    Not Confirmed
    arrow

    Bayer AG

    Germany
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    Antihemophilic factor recombinant

    Brand Name : JIVI

    Dosage Form : POWDER FOR SOLUTION

    Dosage Strength : 3000UNIT/VIAL

    Packaging :

    Approval Date :

    Application Number : 2481790

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Novo Nordisk

    Denmark
    IOPC
    Not Confirmed
    arrow

    Novo Nordisk

    Denmark
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    Antihemophilic factor recombinant

    Brand Name : ESPEROCT

    Dosage Form : POWDER FOR SOLUTION

    Dosage Strength : 500UNIT/VIAL

    Packaging :

    Approval Date :

    Application Number : 2490064

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Novo Nordisk

    Denmark
    IOPC
    Not Confirmed
    arrow

    Novo Nordisk

    Denmark
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    Antihemophilic factor recombinant

    Brand Name : ESPEROCT

    Dosage Form : POWDER FOR SOLUTION

    Dosage Strength : 1000UNIT/VIAL

    Packaging :

    Approval Date :

    Application Number : 2490072

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    11

    Novo Nordisk

    Denmark
    IOPC
    Not Confirmed
    arrow

    Novo Nordisk

    Denmark
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    Antihemophilic factor recombinant

    Brand Name : ESPEROCT

    Dosage Form : POWDER FOR SOLUTION

    Dosage Strength : 2000UNIT/VIAL

    Packaging :

    Approval Date :

    Application Number : 2490099

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    12

    Novo Nordisk

    Denmark
    IOPC
    Not Confirmed
    arrow

    Novo Nordisk

    Denmark
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    Antihemophilic factor recombinant

    Brand Name : ESPEROCT

    Dosage Form : POWDER FOR SOLUTION

    Dosage Strength : 3000UNIT/VIAL

    Packaging :

    Approval Date :

    Application Number : 2490102

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    13

    Takeda Pharmaceutical

    Japan
    IOPC
    Not Confirmed
    arrow

    Takeda Pharmaceutical

    Japan
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    Antihemophilic factor recombinant

    Brand Name : ADYNOVATE

    Dosage Form : KIT

    Dosage Strength : 250UNIT/VIAL

    Packaging :

    Approval Date :

    Application Number : 2498537

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    14

    Takeda Pharmaceutical

    Japan
    IOPC
    Not Confirmed
    arrow

    Takeda Pharmaceutical

    Japan
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    Antihemophilic factor recombinant

    Brand Name : ADYNOVATE

    Dosage Form : KIT

    Dosage Strength : 500UNIT/VIAL

    Packaging :

    Approval Date :

    Application Number : 2498545

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    15

    Takeda Pharmaceutical

    Japan
    IOPC
    Not Confirmed
    arrow

    Takeda Pharmaceutical

    Japan
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    Antihemophilic factor recombinant

    Brand Name : ADYNOVATE

    Dosage Form : KIT

    Dosage Strength : 1000UNIT/VIAL

    Packaging :

    Approval Date :

    Application Number : 2498588

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    16

    Takeda Pharmaceutical

    Japan
    IOPC
    Not Confirmed
    arrow

    Takeda Pharmaceutical

    Japan
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    Antihemophilic factor recombinant

    Brand Name : ADYNOVATE

    Dosage Form : KIT

    Dosage Strength : 3000UNIT/VIAL

    Packaging :

    Approval Date :

    Application Number : 2498626

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    17

    Takeda Pharmaceutical

    Japan
    IOPC
    Not Confirmed
    arrow

    Takeda Pharmaceutical

    Japan
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    Antihemophilic factor recombinant

    Brand Name : ADYNOVATE

    Dosage Form : KIT

    Dosage Strength : 2000UNIT/VIAL

    Packaging : 5ML

    Approval Date :

    Application Number : 2459078

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    18

    Takeda Pharmaceutical

    Japan
    IOPC
    Not Confirmed
    arrow

    Takeda Pharmaceutical

    Japan
    arrow
    IOPC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule D

    Registration Country : Canada

    Antihemophilic factor recombinant

    Brand Name : OBIZUR

    Dosage Form : POWDER FOR SOLUTION

    Dosage Strength : 500UNIT/ML

    Packaging : 1ML RECONST. IN 3ML VIAL

    Approval Date :

    Application Number : 2447401

    Regulatory Info : Schedule D

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF